Prognostic Value of Multiple Complete Blood Count-Derived Indices in Intermediate Coronary Lesions

Yuxiu Yang1, Chenxi Song1, Lei Jia1

  • 1Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Angiology
|August 30, 2023
PubMed

Insights

The Systemic Inflammation Response Index (SIRI) is a key inflammatory biomarker for predicting major adverse cardiovascular events in patients with intermediate coronary stenosis. SIRI and AISI showed the strongest prognostic value, enhancing risk prediction beyond traditional models.

Area of Science:

  • Cardiology
  • Inflammation Biomarkers
  • Predictive Analytics

Background:

  • Complete blood count (CBC)-derived indices are emerging as potential inflammatory biomarkers for cardiovascular disease outcomes.
  • Validation of these indices in patients with intermediate coronary stenosis is limited.

Purpose of the Study:

  • To evaluate the prognostic value of various CBC-derived inflammatory indices in patients with intermediate coronary stenosis.
  • To identify the most effective index for predicting major adverse cardiovascular events (MACEs).

Main Methods:

  • A cohort of 1527 patients with intermediate coronary stenosis was analyzed.
  • Neutrophil-lymphocyte ratio (NLR), derived NLR, monocyte-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR), systemic immune inflammation index (SII), system inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) were examined.
  • The primary endpoint was a composite of MACEs over a median follow-up of 6.11 years.

Main Results:

  • The Systemic Inflammation Response Index (SIRI) demonstrated the highest predictive power, evidenced by the largest area under the receiver operator characteristic curve.
  • In multivariable analysis, SIRI (HR 1.588) and Aggregate Index of Systemic Inflammation (AISI) (HR 1.673) were significant independent predictors of MACEs.
  • Predictive performance of these indices improved in patients with a lower burden of modifiable cardiovascular risk factors, with SIRI offering the best incremental value.

Conclusions:

  • CBC-derived indices, particularly SIRI and AISI, are valuable prognostic markers for MACEs in patients with intermediate coronary stenosis.
  • SIRI shows superior performance and incremental predictive value compared to other inflammatory indices and traditional risk models.
  • These findings support the use of SIRI in risk stratification for patients with intermediate coronary stenosis.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9